Skip to main navigation

About Xeris
Products
- Overview
- Gvoke
- Recorlev
- Keveyis
Research & Development
Investors
Careers
Data Security Notice
Contact Us

FAQs
Email Alerts
Contact Investor Relations
RSS Feeds

Contact Investor Relations

Allison Wey
Senior Vice President Investor Relations & Corporate Communications
Email: IR@xerispharma.com
Phone: 844.445.5704

Contact form

Name

Email

Subject

Comments

Leave this field blank

Request email alerts

Print Page
RSS
IR Contacts

Gvoke^®, Gvoke HypoPen^®, XeriSol^TM, XeriJect^®, Xeris Pharmaceuticals^®, Ogluo^®, Keveyis^®, Recorlev^®,Gvoke HypoPen 2-Pack^TM, XerisCareConnection^TM, PPP MentorConnect^TM , droplet design, and their associated logos are trademarks owned by or licensed to Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings, Inc. All other trademarks are the property of their respective owners.

Contact us
Terms of use
Privacy policy
Data Privacy Framework Policy
Financial conflict of interest policy
Accessibility Statement

Copyright ©2024 Xeris Pharmaceuticals, Inc. All rights reserved. US-CORP-22-00117

Search

Search this site